Enzon Pharmaceuticals Inc. (OTCMKTS:ENZN – Get Free Report) passed above its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $0.06 and traded as high as $0.06. Enzon Pharmaceuticals shares last traded at $0.06, with a volume of 602 shares.
Enzon Pharmaceuticals Price Performance
The company’s fifty day moving average price is $0.06 and its 200 day moving average price is $0.06. The company has a market cap of $4.23 million, a PE ratio of -0.81 and a beta of 0.20.
Enzon Pharmaceuticals (OTCMKTS:ENZN – Get Free Report) last released its quarterly earnings results on Monday, March 2nd. The biotechnology company reported ($0.02) earnings per share for the quarter.
About Enzon Pharmaceuticals
Enzon Pharmaceuticals, Inc, headquartered in Piscataway, New Jersey, is a specialized biopharmaceutical company best known for pioneering polyethylene glycol (PEG) technology to enhance the pharmacokinetic properties of therapeutic proteins. Founded in 1981, Enzon has leveraged its PEGylation platform to develop an array of oncology and hematology products with improved half-life and reduced immunogenicity.
The company’s flagship product, Oncaspar (pegaspargase), was originally approved for the treatment of acute lymphoblastic leukemia in pediatric and adult patients, highlighting Enzon’s commitment to oncology.
Further Reading
- Five stocks we like better than Enzon Pharmaceuticals
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Enzon Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enzon Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
